JP2014525417A5 - - Google Patents

Download PDF

Info

Publication number
JP2014525417A5
JP2014525417A5 JP2014527355A JP2014527355A JP2014525417A5 JP 2014525417 A5 JP2014525417 A5 JP 2014525417A5 JP 2014527355 A JP2014527355 A JP 2014527355A JP 2014527355 A JP2014527355 A JP 2014527355A JP 2014525417 A5 JP2014525417 A5 JP 2014525417A5
Authority
JP
Japan
Prior art keywords
eluate
concentration
cation exchange
exchange resin
separately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527355A
Other languages
English (en)
Japanese (ja)
Other versions
JP6165143B2 (ja
JP2014525417A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/052567 external-priority patent/WO2013033042A1/en
Publication of JP2014525417A publication Critical patent/JP2014525417A/ja
Publication of JP2014525417A5 publication Critical patent/JP2014525417A5/ja
Application granted granted Critical
Publication of JP6165143B2 publication Critical patent/JP6165143B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527355A 2011-08-26 2012-08-27 血漿由来の免疫グロブリン組成物の血栓塞栓症の可能性を軽減する方法 Active JP6165143B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161527974P 2011-08-26 2011-08-26
US61/527,974 2011-08-26
PCT/US2012/052567 WO2013033042A1 (en) 2011-08-26 2012-08-27 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Publications (3)

Publication Number Publication Date
JP2014525417A JP2014525417A (ja) 2014-09-29
JP2014525417A5 true JP2014525417A5 (https=) 2015-10-15
JP6165143B2 JP6165143B2 (ja) 2017-07-19

Family

ID=46970397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527355A Active JP6165143B2 (ja) 2011-08-26 2012-08-27 血漿由来の免疫グロブリン組成物の血栓塞栓症の可能性を軽減する方法

Country Status (19)

Country Link
US (1) US9403899B2 (https=)
EP (1) EP2748193B1 (https=)
JP (1) JP6165143B2 (https=)
KR (1) KR101949553B1 (https=)
CN (1) CN103874708B (https=)
AR (1) AR087953A1 (https=)
AU (1) AU2012300220C1 (https=)
BR (1) BR112014004445B1 (https=)
CA (1) CA2846599A1 (https=)
CL (1) CL2014000480A1 (https=)
CO (1) CO6920256A2 (https=)
EA (1) EA030251B1 (https=)
ES (1) ES2624485T3 (https=)
IL (1) IL231083B (https=)
MX (1) MX349005B (https=)
MY (1) MY165164A (https=)
SG (1) SG11201400233TA (https=)
TW (1) TWI610937B (https=)
WO (1) WO2013033042A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
KR101917197B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
KR101917196B1 (ko) 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
EP3275897A1 (en) 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
US11814442B2 (en) 2017-06-12 2023-11-14 Kamada Ltd. Immunoglobulin compositions and process for obtaining the same
CN119300842A (zh) * 2022-05-02 2025-01-10 武田药品工业株式会社 通过超滤从血浆制备科恩池浓缩物的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (https=) 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
DK166763C (da) 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
DE3483784D1 (de) 1984-07-07 1991-01-31 Woelm Pharma Gmbh & Co Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
DE3640513A1 (de) 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE59309332D1 (de) * 1993-12-27 1999-03-04 Rotkreuzstiftung Zentratrallab Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
GB9610992D0 (en) 1996-05-24 1996-07-31 Glaxo Group Ltd Concentrated antibody preparation
US6162904A (en) 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
TWI445714B (zh) * 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof

Similar Documents

Publication Publication Date Title
JP2014525417A5 (https=)
KR101569783B1 (ko) 항체의 정제 방법
JP2007532477A5 (https=)
JP6592426B2 (ja) 無塩条件下で疎水性相互作用クロマトグラフィーを使用するタンパク質精製
Vançan et al. IMAC of human IgG: studies with IDA-immobilized copper, nickel, zinc, and cobalt ions and different buffer systems
RU2014111820A (ru) Способы элиминации вируса
JP2017517745A5 (https=)
JP2016519137A5 (https=)
JP2013514073A5 (https=)
JP2018087207A (ja) 高純度の組換えヒト血清アルブミンを単離、精製するクロマトグラフ法
JP2016530533A5 (https=)
Zhang et al. A method for improving protein A chromatography's aggregate removal capability
WO2015067147A1 (zh) 重组蛋白质的纯化方法
GB2443505B (en) Nucleic acid purification method
Yang et al. Effect of cleaning agents and additives on Protein A ligand degradation and chromatography performance
Scheffel et al. Highly selective Protein A resin allows for mild sodium chloride-mediated elution of antibodies
JP2012510500A5 (https=)
Senczuk et al. Hydrophobic interaction chromatography in dual salt system increases protein binding capacity
BR112016027930B1 (pt) recuperação de prata por meio de troca de íons
CN114656551B (zh) 一种去除双特异性或复杂构型抗体宿主细胞蛋白残留的亲和纯化工艺
KR102490458B1 (ko) 68Ge/68Ga 발생기로부터 유래하는 용출물로부터 Ga-68을 정제하는 방법 및 이러한 방법에 사용하기 위한 크로마토그래피 컬럼
CN103505908B (zh) 一种利用混合模式层析介质连续分离纯化抗体的方法
CN103694343B (zh) 一种从尿液中制备人血白蛋白的方法
CN103739692B (zh) 一种制备β2微球蛋白粗制品的方法
JP2016151062A (ja) Pt含有溶液からの不純物元素の除去方法及びそれを用いたPtの回収方法